本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ensysce Biosciences Inc.

0.5559
+0.02895.48%
盘前:0.5394-0.0165-2.97%08:16 EDT
成交量:131.62万
成交额:70.37万
市值:1,081.60万
市盈率:-0.20
高:0.5646
开:0.5100
低:0.4854
收:0.5270
52周最高:2.75
52周最低:0.2300
股本:1,945.68万
流通股本:1,837.90万
量比:1.25
换手率:7.16%
股息:- -
股息率:- -
每股收益(TTM):-2.7523
每股收益(LYR):-3.9790
净资产收益率:-1295.09%
总资产收益率:-185.51%
市净率:-13.84
市盈率(LYR):-0.14

数据加载中...

2022/02/08

重要事件披露

8-K - Current report
2022/01/31

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/27

重要事件披露

8-K - Current report
2022/01/18

重要事件披露

8-K - Current report
2021/12/27

重要事件披露

8-K - Current report
2021/11/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/29

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/25

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/10/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/07

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/09/27

重要事件披露

8-K - Current report
2021/09/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/17

重要事件披露

8-K - Current report
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/09

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/07/21

重要事件披露

8-K - Current report
2021/07/12

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/12

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/12

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership